Aurobindo Pharma

BSE : 524804 | NSE : AUROPHARMA

Industry : Pharmaceuticals | ISIN : INE406A01037 | FreeFloat : 50.00% | FnO : Yes | LotSize : 650


Intellectual Capital (IC)26,529.01
Net Worth (NW)22,919.05
Intrinsic Worth (IW)49,448.05
Market Cap (MC)56,554.80
Economic Value Added-142.57
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)53.65%
IC Gross Margin (EBITDA/IC)21.70%
IC Net Margin (NPT/IC)13.86%
Knowledge Turnover (Sales/IC)0.91
Market to Intrinsic Value (MC/IW)1.14

As OfIntrinsic ValueMarket Price
30 Jun 2021Rs. 843.91Rs. 965.20
20 Sep 2021 ---- Rs. 712.40
-33.80     -4.74%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 744.26SellStrong Sell
KB > 50% : Yes50 DMA : Rs. 827.78
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Sep-18
C
4751.40
4777.66
985.93
822.25
786.86
611.44
803.06
Dec-18
C
5269.67
5333.52
1127.76
964.64
916.99
712.21
538.78
Mar-19
C
5292.20
5324.47
1053.04
866.42
816.34
585.22
528.36
Jun-19
C
5444.60
5460.38
1154.19
913.33
863.44
635.68
645.76
Sep-19
C
5600.47
5621.09
1148.15
904.84
863.90
639.53
656.60
Dec-19
C
5895.00
5925.93
1225.41
975.28
938.17
705.31
816.53
Mar-20
C
6158.43
6191.02
1341.75
1109.34
1077.51
848.99
997.73
Jun-20
C
3419.70
3545.28
1090.41
970.62
960.19
714.68
711.55
Sep-20
C
6483.44
6537.19
1466.03
1208.69
1192.98
805.65
762.79
Dec-20
C
6364.91
6498.31
1487.52
1211.00
1191.51
876.46
950.86
Mar-21
C
6001.50
6079.60
1345.09
1079.09
1060.87
801.18
719.81
Jun-21
C
5701.98
5811.88
1310.28
1030.59
1017.71
769.97
989.99
* C - Consolidated, S - Standalone